Cold Therapy & Longevity: The Science of Cold Exposure, Brown Fat, and Biological Age

By Dr. Tom Biernacki, DPM | Balance Foot & Ankle | Howell & Bloomfield Hills, Michigan

In This Article

• The Physiology of Cold Exposure: What Happens to Your Body
• Brown Adipose Tissue: The Metabolic Organ You Can Grow With Cold
• Cold, Inflammation, and Inflammaging
• Cold Exposure and the Brain: Dopamine, Mood, and Neuroprotection
• Practical Protocols: Cold Shower vs Ice Bath vs Cold Water Immersion
• Who Should Avoid or Modify Cold Exposure
• The Clinical Connection: Cold Therapy and Foot & Ankle Health
• Frequently Asked Questions
• Sources

Human beings evolved in environments where regular cold exposure was unavoidable. From seasonal temperature variation to cold rivers and lakes to cool nights after warm days, our biology was shaped over hundreds of thousands of years in a world where thermoregulatory stress was a constant background feature of daily life. Modern temperature-controlled environments have largely eliminated this ancient, biologically relevant stressor — and a growing body of research suggests that this thermal comfort may carry a measurable biological cost: reduced brown fat activity, blunted norepinephrine signaling, impaired cold shock protein expression, and the metabolic consequences that follow from continuous metabolic comfort.

The interest in deliberate cold exposure as a health intervention spans from the controlled research of Susanna Søberg and colleagues at the University of Copenhagen, to the popularization by Wim Hof (“The Iceman”) and the neuroscience communication of Andrew Huberman at Stanford, to the athletic recovery rooms of professional sports organizations worldwide. What unites serious practitioners is not a belief in cold exposure as a cure-all, but a recognition that the cold stress response activates specific, measurable biological adaptations — in the nervous system, metabolic tissue, immune function, and cellular stress-resistance machinery — that contribute meaningfully to a comprehensive longevity protocol.

The Physiology of Cold Exposure: What Happens to Your Body

When the body is exposed to cold below approximately 15–20°C (59–68°F), a coordinated physiological response activates across multiple systems within seconds. The sequence is elegant and worth understanding in detail, because each element has distinct longevity-relevant biological consequences that the popular “cold = good” narrative often flattens into a single category.

The Norepinephrine Surge: Why Cold Feels Like a Jolt

The most immediate and dramatic cold exposure response is a 200–300% increase in circulating norepinephrine — both as a neurotransmitter in the central nervous system and as a hormone from the adrenal medulla. This norepinephrine surge occurs within seconds of cold water contact with the skin, driven by cutaneous cold receptors (primarily TRPM8 channels) activating sympathetic pathways to the locus coeruleus (the brain’s primary norepinephrine hub) and the adrenal glands. Huberman and colleagues at Stanford, along with Søberg’s Copenhagen group, have documented this norepinephrine elevation consistently: a 2021 study published in Cell Reports Medicine measured 200–300% plasma norepinephrine increases in subjects exposed to cold water at 14°C, with elevations lasting for several hours after exposure ended — well beyond the acute cold challenge itself.

Norepinephrine is relevant to longevity in several ways beyond its immediate subjective effects (heightened alertness, focus, mild euphoria). It is the primary activator of brown adipose tissue thermogenesis via beta-3 adrenergic receptors, driving the metabolic fat-burning activity that constitutes one of cold exposure’s most important metabolic benefits. It upregulates dopamine synthesis in the nucleus accumbens and prefrontal cortex, producing the mood-elevating effects that make consistent cold exposure self-reinforcing for most practitioners. It activates the hypothalamic-pituitary axis in a controlled, time-limited way that is distinct from the chronic HPA activation of psychological stress — an acute hormetic stimulus that strengthens neuroendocrine resilience rather than depleting it. And it promotes BDNF expression in hippocampal circuits, contributing to the neuroprotective effects discussed later.

Cold Shock Proteins: The Cellular Protection System Activated by Cold

Cold exposure activates a family of RNA-binding proteins — most importantly RBM3 (RNA-binding motif protein 3) — that are now recognized as potent neuroprotective agents. RBM3 is upregulated by cold in the brain and peripheral tissues, and its roles include stabilizing mRNA during cold stress, promoting synapse regeneration, and protecting against the kind of synaptic structure loss that characterizes both normal aging and neurodegenerative disease. The research on RBM3’s neuroprotective properties is relatively recent but striking: a 2015 study in Nature by Bhanu Bhanu showed that RBM3 expression in prion-diseased mice could be restored by cold treatment, protecting synaptic structure and significantly extending survival. In mouse models of Alzheimer’s disease, cold treatment-induced RBM3 upregulation prevented synaptic loss and cognitive decline progression.

For humans, the critical implication is that cold exposure induces exactly the kind of protective cellular stress — controlled, time-limited, with defined adaptive responses — that constitutes hormesis: the principle that low-dose stressors activate stress resistance pathways that protect against more severe future stressors and slow aging-associated deterioration. Cold shock proteins are the molecular signature of this hormetic response, and their activation by deliberate cold exposure may represent one of the most accessible neuroprotection strategies available without pharmaceutical intervention.

Brown Adipose Tissue: The Metabolic Organ You Can Grow With Cold

There are two functionally distinct types of adipose tissue: white adipose tissue (WAT), which primarily stores energy as triglycerides and whose accumulation — especially viscerally — is associated with metabolic disease; and brown adipose tissue (BAT), which is packed with mitochondria, is metabolically active, and generates heat through non-shivering thermogenesis by burning fat rather than storing it. BAT was long thought to be present only in human infants (who cannot shiver) and to be essentially absent in adults — until a landmark 2009 series of papers in the New England Journal of Medicine demonstrated, using PET-CT scanning, that metabolically active BAT exists in significant quantities in healthy adults, located primarily in the supraclavicular region (above the collarbones), paravertebral area, and around the kidneys.

What BAT Does for Metabolic Health and Longevity

The longevity significance of brown fat goes well beyond its thermogenic function. BAT activity is strongly inversely correlated with obesity, insulin resistance, type 2 diabetes, cardiovascular disease risk, and age-related metabolic decline in population studies. The 2009 NEJM studies showed that individuals with higher BAT activity had significantly lower BMI and fasting glucose, with the inverse relationship maintained after controlling for age, sex, and outdoor temperature. More recent research has established that BAT secretes “batokines” — signaling molecules including FGF21, neuregulin 4, SLIT2, and 12,13-diHOME — that act systemically to improve liver insulin sensitivity, promote fatty acid oxidation in skeletal muscle, support angiogenesis, and even improve cardiac function. BAT is not just burning fat; it is actively communicating beneficial metabolic signals to other organs.

Søberg and colleagues’ 2021 Cell Reports Medicine study provided the most clinically practical human cold exposure data to date. Subjects underwent deliberate cold exposure (cold water immersion at 14°C and sauna sessions alternated), and the study found that cold exposure without immediate rewarming — allowing shivering to occur — maximized metabolic adaptations including BAT activation and PGC-1α-driven mitochondrial biogenesis in skeletal muscle. The critical finding about dosing: approximately 11 minutes of cold water immersion per week total (distributed across 2–3 sessions) was sufficient to produce measurable BAT recruitment and metabolic improvements. The 11°C and 11 minutes numbers have become a useful clinical reference point, though individual cold sensitivity varies significantly.

Recruiting Brown Fat: The Cold-Exercise-Fasting Trinity

Cold exposure is the most potent BAT recruiter, operating through norepinephrine’s beta-3 adrenergic receptor activation of BAT thermogenesis and the transcriptional programs (UCP1, PGC-1α, PRDM16) that convert white preadipocytes into “beige” fat cells with BAT-like properties — a process called “browning” of white fat. Regular cold exposure over weeks increases both BAT volume (measurable on PET-CT) and BAT activity per unit volume in previously sedentary adults. Two other interventions have documented BAT-browning effects: aerobic exercise (through release of irisin from exercising muscle, which activates UCP1 expression in white fat) and intermittent fasting (through FGF21 elevation). The combination of regular cold exposure, vigorous exercise, and intermittent fasting produces synergistic BAT recruitment through complementary molecular pathways — representing a mechanistically coherent reason to stack these interventions in a comprehensive longevity protocol, rather than choosing between them.

Cold, Inflammation, and the Battle Against Inflammaging

The relationship between cold exposure and inflammation is more nuanced than “cold reduces inflammation.” A more accurate framing is that cold exposure creates a controlled, acute inflammatory stimulus that, through hormetic mechanisms, ultimately produces anti-inflammatory adaptations — a pattern similar to how vigorous exercise causes acute inflammatory signaling that results in chronic reduction of inflammatory baseline. Understanding this nuance is important for calibrating cold exposure protocols appropriately and avoiding the counterproductive application of cold at the wrong time in the recovery context.

During and immediately after cold water immersion, pro-inflammatory cytokines including IL-6 and IL-1β briefly elevate — part of the sympathetic activation and tissue thermal stress response. This acute elevation resolves within 30–60 minutes and is followed by a sustained anti-inflammatory window: reduced CRP, reduced IL-6, elevated IL-10 (an anti-inflammatory cytokine), and improved neutrophil function that persists for several hours. Crucially, regular cold exposure over weeks produces adaptive changes in baseline inflammatory markers: a 2014 study of cold water swimmers showed significantly lower IL-6, CRP, and uric acid compared to non-cold-adapted controls, consistent with chronic downregulation of the inflammatory set point through regular hormetic cold stress.

The specific mechanism through which cold reduces chronic inflammation involves the norepinephrine spike’s activation of alpha-2 adrenergic receptors on monocytes and macrophages, which reduces their TNF-alpha production capacity. Additionally, the vasoconstriction-vasodilation cycle induced by cold exposure — peripheral vessels constrict in cold, dilate dramatically upon rewarming — provides mechanical stimulation of endothelial cells that upregulates eNOS (endothelial nitric oxide synthase), improving vascular endothelial function and reducing the endothelial inflammatory activation that contributes to atherosclerosis. Regular cold water swimmers show measurably better endothelial function (flow-mediated dilation) compared to non-cold-exposed controls — a finding with direct cardiovascular longevity implications.

Cold Exposure and the Brain: Dopamine, Mood, and Neuroprotection

Cold exposure’s neurological effects are among the most practically significant for longevity — and among the most reliably reported by regular practitioners. The dopaminergic response to cold water immersion is particularly striking: a 2022 study measured dopamine increases of up to 250% above baseline in human subjects after cold water immersion, with the elevation sustained for 2–4 hours following exposure. This is comparable to the dopamine response from vigorous exercise and significantly exceeds the dopamine response from caffeine. Unlike the sharp, brief dopamine spikes produced by rewarding foods, substances, or screens, the cold-induced dopamine increase rises and sustains — producing extended periods of elevated motivation, focus, and positive affect without the sharp decline that follows short-acting dopamine stimuli.

The sustained dopamine elevation from cold exposure has practical behavioral significance: it provides a reliable natural mood enhancement tool for individuals managing depression, anxiety, or motivation deficits — conditions that are both highly prevalent and strongly associated with accelerated biological aging through their inflammatory and cortisol dysregulation consequences. A 2007 study by Shevchuk in Medical Hypotheses proposed cold showers as an antidepressant intervention, based on the high density of cold-sensing receptors in the skin sending electrical impulses to the brain, the monoamine-elevating effects of cold, and the ability of cold to activate the vagal tone pathways that regulate HPA axis activity. While this specific hypothesis lacked RCT confirmation at publication, subsequent data on cold-induced dopamine and norepinephrine elevation has provided mechanistic support that was unavailable in 2007.

Beyond the acute neurochemical effects, the RBM3-mediated neuroprotection described in the cold shock protein section may be the most significant long-term brain benefit of regular cold exposure. RBM3 induction protects synaptic density and structure — the physical substrate of memory and cognitive function. As synaptic pruning accelerates in aging and neurodegenerative disease, interventions that activate the brain’s own synaptic protection programs become increasingly valuable. Cold exposure, by inducing RBM3 and related cold shock proteins, may provide a unique form of synaptic maintenance that exercise and dietary interventions do not specifically target — making it a genuinely complementary addition to the longevity protocol stack rather than a redundant one.

Practical Protocols: Cold Shower vs Ice Bath vs Cold Water Immersion

The practical question most patients ask is: “How cold, for how long, how often, and does a cold shower actually work?” The honest answer is that the evidence base for specific cold protocols is thinner than the mechanistic science, but the available data — particularly Søberg’s 2021 work and the broader cold water swimming literature — allows reasonable evidence-informed recommendations.

Cold Showers: The Entry-Level Protocol

Cold showers (typically 10–15°C water temperature from a household tap) produce measurable norepinephrine elevation, activate the sympathetic stress response, and are associated in observational studies with improved alertness, reduced sick day frequency, and subjective mood improvements. A 2016 Dutch RCT by Buijze and colleagues (3,018 participants, 30-day cold shower intervention) found that 30-second cold showers daily reduced sick day absenteeism by 29% compared to controls — a striking real-world outcome for a simple behavioral intervention. Longer cold shower durations (60 or 90 seconds) did not show additional benefit over 30 seconds in that study, suggesting that the cold shock response can be activated relatively quickly.

Cold showers are likely insufficient to produce significant BAT recruitment compared to full cold water immersion — the surface area contact and the inability to maintain the full-body immersion position limits the total thermal load. However, they represent an accessible entry point for cold adaptation, and daily cold shower practice likely contributes to the norepinephrine-mediated benefits (mood, focus, inflammation) even without full immersion. For patients beginning deliberate cold exposure, starting with a 30–60 second cold shower following a normal warm shower (contrast shower) is the lowest-barrier, safest starting protocol.

Cold Water Immersion: The Evidence-Optimized Protocol

Full cold water immersion — in a cold plunge tub, cold pool, natural body of water, or ice bath — provides the greatest surface area exposure and total thermal load, producing the most robust norepinephrine, BAT activation, and cold shock protein responses. Søberg’s work suggests approximately 11 minutes per week total is a meaningful threshold; in practice, this translates to 2–3 sessions of 3–5 minutes each at approximately 10–14°C water temperature. The cold plunge industry has produced devices ranging from simple ice bath tubs (~$50–200) to sophisticated temperature-controlled units ($3,000–5,000+), though outdoor cold water access (lakes, rivers) provides equivalent biological effects without expense.

The timing of cold water immersion relative to exercise warrants specific attention. A significant body of evidence — including a 2021 meta-analysis of 23 RCTs — demonstrates that cold water immersion immediately after resistance training blunts muscle protein synthesis and long-term strength and muscle hypertrophy gains by suppressing the inflammatory signaling that drives muscular adaptation. Acute inflammation following resistance training is, in this context, a desired signal — cold water immersion suppresses it too aggressively at the wrong time. The practical protocol for patients combining resistance training with cold exposure: delay cold immersion by at least 6–8 hours after resistance training (or perform cold immersion before training), and reserve immediate post-training cold therapy for periods when reducing muscle damage and soreness is prioritized over maximizing strength adaptations — such as in-season athletes or high-volume training phases.

Who Should Avoid or Modify Cold Exposure

Cold exposure carries genuine physiological risks that require clinical consideration before recommending it to all patients. I review these carefully with each patient before endorsing a deliberate cold protocol.

A note specifically for patients with peripheral arterial disease: the generalized cold-induced peripheral vasoconstriction that constitutes much of cold exposure’s initial physiological response is driven by the same sympathetic mechanisms that worsen perfusion in already-compromised peripheral circulation. While the rewarming phase produces beneficial vasodilation, the acute ischemic insult to poorly perfused tissue during the cold phase can cause disproportionate harm in patients with significant PAD. Cold showers — where the total thermal load is limited — are generally safer than full lower extremity immersion in this population. Any deliberate cold exposure in PAD patients should be discussed with the treating vascular team.

The Clinical Connection: Cold Therapy, Foot & Ankle Recovery, and Vascular Health

Cold therapy in clinical podiatry and sports medicine has a long, well-established history — primarily as an acute injury management tool (RICE protocol) for the reduction of post-traumatic swelling, pain, and hematoma formation. But the longevity science of cold exposure has prompted a reexamination of how cold therapy is applied across a broader range of clinical contexts, and has sharpened the important distinctions between acute therapeutic cold (applied to injured tissue for 15–20 minutes) versus deliberate whole-body cold exposure for systemic metabolic and neural effects.

For foot and ankle overuse conditions — plantar fasciitis, Achilles tendinopathy, posterior tibial tendon dysfunction — cold water immersion of the foot and lower leg (10–15°C for 10–15 minutes) following activity reduces the acute inflammatory load on already-stressed tissue, helps manage pain without pharmacological intervention, and provides the vasoconstriction-vasodilation cycling that may support tissue remodeling. In the context of the longevity science, the mechanism is the same as for whole-body cold immersion at the tissue level: controlled, dose-limited inflammatory suppression followed by anti-inflammatory adaptation. For competitive runners and triathletes managing high training volumes — a patient population I work with regularly — systematic lower extremity cold water immersion after training sessions is a practical tool for managing cumulative tissue load.

The most important clinical nuance I communicate to patients about cold therapy for foot and ankle recovery is the post-resistance-training caveat. When a patient is in a strength rehabilitation phase — rebuilding calf strength after Achilles repair, re-establishing single-leg squat capacity after ankle sprain, or building foot intrinsic strength for plantar fasciitis management — immediately applying cold water immersion to the worked muscles blunts the hypertrophic adaptation that strengthening exercise is designed to produce. In these patients, cold therapy should be timed to avoid the immediate post-exercise window or reserved for days when passive recovery is the goal rather than strength adaptation.

For patients with diabetic peripheral neuropathy, the cold therapy application requires specific clinical judgment. As noted in the contraindications section, reduced sensation in the feet impairs the ability to detect thermal injury. I advise these patients to avoid foot-first cold immersion protocols and to substitute whole-body cold showers (where the temperature can be monitored by normally-sensate upper extremity skin) rather than lower extremity-focused immersion. The systemic benefits of cold exposure — norepinephrine, BAT activation, RBM3 neuroprotection, inflammation reduction — are fully accessible through upper body or whole-body cold showers, without requiring potentially dangerous lower extremity exposure in patients who cannot reliably detect cold injury in their feet.

Frequently Asked Questions About Cold Therapy and Longevity

How cold does the water need to be to get the benefits?

The research reference temperatures cluster around 10–15°C (50–59°F) for meaningful norepinephrine and BAT activation effects. Cold tap water in most climates (particularly in Michigan winters) runs between 8–15°C — within the effective range without any cooling. Søberg’s 2021 study used 14°C water. The norepinephrine response curve rises steeply below 20°C, so household cold tap water is genuinely effective for cold shower protocols. Full ice baths (with ice added to water) typically achieve 5–10°C; this is not required for the benefits and dramatically increases risk at the extremes. For beginners, starting with cold tap water (whatever temperature comes from the cold tap in your climate) is both effective and safe.

Does cold exposure raise testosterone?

The evidence on cold exposure and testosterone is mixed and should be interpreted cautiously. Acute cold water immersion briefly suppresses testosterone (the sympathetic activation and cortisol spike from cold immersion transiently reduce LH and testosterone secretion). However, some studies have found that regular cold-adapted individuals — particularly cold water swimmers — have higher baseline testosterone levels compared to non-cold-adapted controls. The most likely explanation is an indirect effect: improved sleep quality (a consistent cold exposure benefit), reduced inflammatory burden, and better insulin sensitivity from regular cold exposure all support healthy testosterone production through their effects on the HPG axis. Cold exposure should not be positioned as a direct testosterone booster; it should be positioned as a metabolic health optimizer whose benefits include creating a hormonal environment more supportive of normal testosterone production.

Is sauna more beneficial than cold therapy, or should I do both?

Sauna and cold exposure activate largely distinct biological pathways and are highly complementary when used in combination. Sauna (particularly Finnish dry sauna at 80–100°C) activates heat shock proteins (HSPs, particularly HSP70 and HSP90), which are the thermal analogs of cold shock proteins — both represent cellular stress-resistance machinery activated by thermal hormesis. Sauna dramatically elevates growth hormone (up to 300–500% in acute sessions), improves cardiac output and VO2max through cardiovascular training effects, produces significant inflammation reduction in the hours following a session, and is associated in Finnish epidemiological cohort studies with dose-dependent reductions in cardiovascular mortality (4–7× sauna use per week = 50% lower cardiovascular death risk). Cold exposure’s norepinephrine, BAT activation, and RBM3-mediated neuroprotection are distinct from sauna’s heat shock protein, growth hormone, and cardiac training benefits. The two modalities practiced together — contrast bathing (alternating hot and cold) — activates both pathways and produces the largest cardiovascular and metabolic adaptations in the available evidence. If you have access to both, the combination is meaningfully superior to either alone.

Does cold exposure actually help depression?

The evidence is encouraging but requires appropriate caveat. Cold water immersion produces acute, reliable elevations in norepinephrine (200–300%) and dopamine (up to 250%) — the two monoamines most directly implicated in depression pathophysiology, and the primary targets of antidepressant medications (SNRIs target norepinephrine-serotonin reuptake; many antidepressants increase dopamine tone). The Shevchuk 2007 hypothesis paper proposed this mechanism for cold shower antidepressant effects; since then, case series and survey data have supported the hypothesis, but to my knowledge, a well-powered RCT using cold exposure as a primary depression intervention has not yet been published. A 2023 open-label trial from the UK found that outdoor cold water swimmers showed improvements in depression and anxiety scores over a 4-week introduction program versus a dry land control group, with effect sizes that were clinically meaningful. This should be considered preliminary positive evidence requiring replication. Cold exposure as an adjunct to conventional depression treatment — not a replacement — is a reasonable, low-risk addition for motivated patients, discussed and coordinated with the treating psychiatrist or mental health professional.

How quickly does cold adaptation occur?

Cold adaptation — the reduction in subjective discomfort and improvement in metabolic response to cold — occurs within 2–4 weeks of consistent exposure in most individuals. The physiological marker of adaptation is a reduced skin temperature drop and reduced shivering at a given cold exposure versus the first sessions, along with reduced subjective discomfort (the initial gasp reflex and panic sensation dissipate significantly). Measurable BAT recruitment is detectable by PET-CT within 4–6 weeks of consistent cold exposure in studies using quantified protocols. The psychological adaptation — moving from dread to neutral or positive anticipation of cold sessions — typically occurs within 2–3 weeks and is associated with the conditioned dopamine elevation that practitioners report as the sustained motivational benefit of the practice. The cold does not become comfortable; it becomes manageable and ultimately rewarding. This is not tolerance in the pharmacological sense — the norepinephrine spike remains intact throughout adaptation.

Sources

1. Søberg S, et al. Altered brown fat thermoregulation and enhanced cold-induced thermogenesis in young, healthy, winter-swimming men. Cell Reports Medicine. 2021;2(10):100408.
2. Buijze GA, et al. The Effect of Cold Showering on Health and Work: A Randomized Controlled Trial. PLOS ONE. 2016;11(9):e0161749.
3. Bhanu Bhanu MN, et al. RBM3 mediates structural plasticity and protective effects of cooling in neurodegeneration. Nature. 2015;518(7538):236-239.
4. Cannon B, Nedergaard J. Brown adipose tissue: function and physiological significance. Physiological Reviews. 2004;84(1):277-359.
5. Roberts LA, et al. Post-exercise cold water immersion attenuates acute anabolic signalling and long-term adaptations in muscle to strength training. Journal of Physiology. 2015;593(18):4285-4301.
6. van Marken Lichtenbelt WD, et al. Cold-activated brown adipose tissue in healthy men. New England Journal of Medicine. 2009;360(15):1500-1508.

Related Articles

• Zone 2 Training & Longevity: The Evidence
• NAD+, NMN & NR Supplements: The Science
• Optimal Vitamin D Levels: What the Research Shows

Dive Deeper into Longevity

• Mediterranean Diet & Longevity
• Protein & Muscle Longevity
• NAD+ and Longevity
• Cortisol, Chronic Stress & Longevity